Seamless phase 2/3 oncology trial design with flexible sample size determination-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Seamless phase 2/3 oncology trial design with flexible sample size determination

Published:2020-04-27 Issue:18 Volume:39 Page:2373-2386
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Teng Zhaoyang¹^ORCID,Tian Yuan²,Liu Yi³,Liu Guohui⁴

Affiliation:

1. Servier Pharmaceuticals Boston Massachusetts USA

2. Department of StatisticsNorth Carolina State University Raleigh North Carolina USA

3. Nektar Therapeutics San Francisco California USA

4. Takeda Pharmaceuticals Inc. Cambridge Massachusetts USA

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.8543

Reference27 articles.

1. Optimal seamless phase 2/3 oncology trial designs based on Probability of Success (PoS)

2. Evaluation of Experiments with Adaptive Interim Analyses

3. Combining different phases in the development of medical treatments within a single trial

4. Testing and estimation in flexible group sequential designs with adaptive treatment selection

5. Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical Trials;Life;2021-11-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP